General Information of Drug Off-Target (DOT) (ID: OTPHOC22)

DOT Name Cell cycle exit and neuronal differentiation protein 1 (CEND1)
Synonyms BM88 antigen
Gene Name CEND1
Related Disease
Beckwith-Wiedemann syndrome ( )
Joubert syndrome ( )
Neuroblastoma ( )
UniProt ID
CEND_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF15677
Sequence
MESRGKSASSPKPDTKVPQVTTEAKVPPAADGKAPLTKPSKKEAPAEKQQPPAAPTTAPA
KKTSAKADPALLNNHSNLKPAPTVPSSPDATPEPKGPGDGAEEDEAASGGPGGRGPWSCE
NFNPLLVAGGVAVAAIALILGVAFLVRKK
Function Involved in neuronal differentiation.
Tissue Specificity Neuron specific.

Molecular Interaction Atlas (MIA) of This DOT

3 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Beckwith-Wiedemann syndrome DISH15GR Strong Genetic Variation [1]
Joubert syndrome DIS7P5CO Strong Biomarker [2]
Neuroblastoma DISVZBI4 Strong Biomarker [1]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the methylation of Cell cycle exit and neuronal differentiation protein 1 (CEND1). [3]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Cell cycle exit and neuronal differentiation protein 1 (CEND1). [9]
------------------------------------------------------------------------------------
9 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Tretinoin DM49DUI Approved Tretinoin increases the expression of Cell cycle exit and neuronal differentiation protein 1 (CEND1). [4]
Cisplatin DMRHGI9 Approved Cisplatin decreases the expression of Cell cycle exit and neuronal differentiation protein 1 (CEND1). [5]
Temozolomide DMKECZD Approved Temozolomide decreases the expression of Cell cycle exit and neuronal differentiation protein 1 (CEND1). [6]
Triclosan DMZUR4N Approved Triclosan decreases the expression of Cell cycle exit and neuronal differentiation protein 1 (CEND1). [7]
Dexamethasone DMMWZET Approved Dexamethasone increases the expression of Cell cycle exit and neuronal differentiation protein 1 (CEND1). [8]
(+)-JQ1 DM1CZSJ Phase 1 (+)-JQ1 increases the expression of Cell cycle exit and neuronal differentiation protein 1 (CEND1). [10]
PMID28460551-Compound-2 DM4DOUB Patented PMID28460551-Compound-2 increases the expression of Cell cycle exit and neuronal differentiation protein 1 (CEND1). [11]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the expression of Cell cycle exit and neuronal differentiation protein 1 (CEND1). [12]
Acetaldehyde DMJFKG4 Investigative Acetaldehyde increases the expression of Cell cycle exit and neuronal differentiation protein 1 (CEND1). [13]
------------------------------------------------------------------------------------
⏷ Show the Full List of 9 Drug(s)

References

1 Cloning, expression and localization of human BM88 shows that it maps to chromosome 11p15.5, a region implicated in Beckwith-Wiedemann syndrome and tumorigenesis.Biochem J. 2001 May 1;355(Pt 3):715-24. doi: 10.1042/bj3550715.
2 Loss of Ahi1 affects early development by impairing BM88/Cend1-mediated neuronal differentiation.J Neurosci. 2013 May 8;33(19):8172-84. doi: 10.1523/JNEUROSCI.0119-13.2013.
3 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
4 Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoS One. 2013 May 28;8(5):e63862.
5 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
6 Temozolomide induces activation of Wnt/-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy. Cell Biol Toxicol. 2020 Jun;36(3):273-278. doi: 10.1007/s10565-019-09502-7. Epub 2019 Nov 22.
7 Transcriptome and DNA methylome dynamics during triclosan-induced cardiomyocyte differentiation toxicity. Stem Cells Int. 2018 Oct 29;2018:8608327.
8 Identification of mechanisms of action of bisphenol a-induced human preadipocyte differentiation by transcriptional profiling. Obesity (Silver Spring). 2014 Nov;22(11):2333-43.
9 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
10 Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma. Oncotarget. 2014 May 15;5(9):2355-71.
11 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.
12 Bisphenol A and bisphenol S induce distinct transcriptional profiles in differentiating human primary preadipocytes. PLoS One. 2016 Sep 29;11(9):e0163318.
13 Transcriptome profile analysis of saturated aliphatic aldehydes reveals carbon number-specific molecules involved in pulmonary toxicity. Chem Res Toxicol. 2014 Aug 18;27(8):1362-70.